探讨超声清创机对儿童烧、烫伤患者创面的愈合疗效。方法:选择2020年1月~2023年1月我科接诊80例烧、烫伤患儿为研究对象,通过使用随机数字表法,将患者随机分配为两个组,每组包含40名患者。这两个组的患者分别接受了不同的伤口敷料更换技术。对照组采用常规换药清创方法,观察组采用超声清创机换药清创方法。观察并分别比较两组患儿的疼痛(VAS)评分、创面细菌培养的结果、创面愈合时间及创面愈合质量。结果:1) 在术后第3天和第7天,观察组儿童的疼痛评分(VAS)明显低于对照组,这种差异在统计学上是显著的(p To explore the curative effect of ultrasonic debridement machine on wound healing in children with burn and scald. Methods: A total of 80 children with burns and scalds treated in our department from January 2020 to January 2023 were selected as the research objects. The patients were randomly assigned to two groups with 40 patients in each group by using random number table method. Patients in both groups received different wound dressing replacement techniques. The control group was treated with conventional debridement and the observation group was treated with ultrasonic debridement. Pain (VAS) score, wound bacteria culture results, wound healing time and wound healing quality of the two groups were observed and compared respectively. Results: 1) On the 3rd and 7th day after surgery, the pain score (VAS) of children in the observation group was significantly lower than that of the control group, and the difference was statistically significant (p < 0.05). 2) In terms of wound bacteria culture, the positive rate of wound culture in the observation group was lower than that in the control group on the 7th and 14th day after surgery, and the difference was statistically significant (p < 0.05). 3) The wound healing time in the observation group was significantly shorter than that in the control group, and the difference between the two groups was statistically significant (p < 0.05). 4) The wound healing quality score (VAS) of the observation group was significantly lower than that of the control group, and the difference was statistically significant (p < 0.05). 5) Compared with the control group, the scar score (VSS) of children in the observation group decreased at 3 months and 6 months after injury, and the differ
目的:评估免疫检查点抑制剂(ICIs)治疗广泛期小细胞肺癌(ED-SCLC)的疗效及发生免疫相关性甲状腺功能紊乱(ir-TD)的风险。方法:系统检索并分析PubMed、Embase、Cochrane Library、Web of Science和Scopus 5个数据库截至2023年8月所有关于...
详细信息
目的:评估免疫检查点抑制剂(ICIs)治疗广泛期小细胞肺癌(ED-SCLC)的疗效及发生免疫相关性甲状腺功能紊乱(ir-TD)的风险。方法:系统检索并分析PubMed、Embase、Cochrane Library、Web of Science和Scopus 5个数据库截至2023年8月所有关于ICIs治疗ED-SCLC的相关研究。结果:通过筛选951篇相关文献,最终有6项研究共2995例患者被纳入Meta分析。与对照组相比,ICIs治疗能显著延长患者的总生存期(HR:0.74,95%CI:0.68~0.81,P<0.001)及无进展生存期(HR:0.68,95%CI:0.60~0.78,P<0.001),客观缓解率(ORR)(RR:1.11,95%CI:1.01~1.23,P=0.03)也优于对照组。然而,ICIs治疗明显增加了甲状腺功能减退(RR:5.80,95%CI:2.18~15.44,P=0.0004)和甲状腺功能亢进(RR:2.76,95%CI:1.76~4.32,P<0.001)的发生风险。结论:ICIs治疗ED-SCLC能明显改善患者预后,延长患者生存期,整体安全性良好,但增加了ir-TD的发生风险。
暂无评论